Citation | DeMong, D; Dai, X; Hwa, J; Miller, M; Lin, SI; Kang, L; Stamford, A; Greenlee, W; Yu, W; Wong, M; Lavey, B; Kozlowski, J; Zhou, G; Yang, DY; Patel, B; Soriano, A; Zhai, Y; Sondey, C; Zhang, H; Lachowicz, J; Grotz, D; Cox, K; Morrison, R; Andreani, T; Cao, Y; Liang, M; Meng, T; McNamara, P; Wong, J; Bradley, P; Feng, KI; Belani, J; Chen, P; Dai, P; Gauuan, J; Lin, P; Zhao, H The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist. J Med Chem57:2601-10 (2014) [PubMed] Article |
---|
SMILES | C[C@H]1CC[C@]2(CC1)N=C(C(=O)N2[C@H](CCC(C)(C)C)c1ccc(cc1)C(=O)NCc1nn[nH]n1)c1cc(Cl)cc(Cl)c1 |r,wU:12.14,1.0,wD:4.3,c:8,(1.27,-23.79,;2.61,-23.02,;2.87,-21.51,;4.32,-20.98,;5.5,-21.96,;5.24,-23.48,;3.79,-24.01,;5.92,-20.48,;7.46,-20.42,;8,-21.87,;9.47,-22.29,;6.78,-22.82,;6.84,-24.36,;5.51,-25.14,;5.53,-26.68,;4.21,-27.47,;4.23,-29.01,;2.86,-26.71,;2.87,-28.22,;8.16,-25.14,;8.14,-26.69,;9.47,-27.47,;10.81,-26.72,;10.83,-25.18,;9.51,-24.4,;12.14,-27.51,;12.12,-29.05,;13.47,-26.76,;14.8,-27.54,;16.14,-26.79,;17.54,-27.42,;18.58,-26.29,;17.83,-24.95,;16.32,-25.25,;8.24,-19.09,;7.48,-17.76,;8.25,-16.43,;7.49,-15.09,;9.8,-16.43,;10.56,-17.77,;12.1,-17.78,;9.78,-19.11,)| |